Incyte to Present New Dermatology Data at 2025 AAD Meeting Incyte (Nasdaq: INCY) today announced that several abstracts showcasing new data from its dermatology portfolio will be presented at the 2025 American Academy of Dermatology (AAD) Annual Meeting, set to…
BeiGene Reports Q4 & Full Year 2024 Financial Results and Update BeiGene, Inc. (NASDAQ: ONC, HKEX: 06160, SSE: 688235), soon to be rebranded as BeOne Medicines Ltd., a global leader in oncology pharmaceuticals, has announced its fourth-quarter and full-year 2024…
BridgeBio Oncology and Helix Acquisition Announce Merger to Create Biotech Company BridgeBio Oncology Therapeutics (BBOT), a clinical-stage biopharmaceutical company focused on developing novel small molecule therapeutics for RAS and PI3Kα-targeted malignancies, and Helix Acquisition Corp. II (Nasdaq: HLXB), a special…
Astria Therapeutics Launches Phase 3 ALPHA-ORBIT Trial of Navenibart for Hereditary Angioedema Astria Therapeutics, Inc. (Nasdaq: ATXS), a biopharmaceutical company dedicated to developing transformative therapies for allergic and immune diseases, has announced the launch of the Phase 3 ALPHA-ORBIT clinical…
Sierra Space to Support Cancer Research on First Dream Chaser® Mission to ISS Sierra Space, a leading commercial space company and defense technology provider, announced new initiatives to advance biopharmaceutical research in low-Earth orbit during the inaugural mission of its…
athenahealth Showcases AI, Interoperability, and Market Solutions at HIMSS 2025 athenahealth, a leading provider of network-enabled software and services for healthcare practices across the country, will be showcasing its innovations at HIMSS, taking place March 3-6. The company will highlight…
Validic Unveils Health IoT and Remote Patient Management Solutions with Generative AI on AWS Marketplace Validic, a leader in healthcare technology innovation, has announced the launch of its full suite of Intelligent Digital Care Solutions and Services on AWS Marketplace.…
Adagio Medical Announces Restructuring to Accelerate US IDE Trial and Innovation Adagio Medical Holdings, Inc. (Nasdaq: ADGM), a leader in catheter ablation technologies for treating cardiac arrhythmias, today announced a strategic restructuring aimed at prioritizing its FULCRUM-VT US pivotal investigational…
Cynosure and Amico Aesthetics Partner for Middle East Distribution Cynosure Lutronic, a global leader in energy-based devices, has entered into a multi-country distribution agreement with Amico Aesthetics, a prominent provider of top-tier medical devices in the Middle East. Effective January…
Waystar Expands Authorization Automation to Meet Healthcare Providers’ 2025 Priorities Waystar (Nasdaq: WAY), a leading provider of healthcare payment software, has introduced the Auth Accelerate solution, a significant enhancement to its automation capabilities aimed at simplifying the prior authorization process…
Compass Pathways Reports Q4 and Full-Year 2024 Financial Results Compass Pathways plc (Nasdaq: CMPS), a leading biotechnology company focused on advancing mental health treatment, has announced its financial results for the fourth quarter and full year of 2024, alongside updates…
Veradigm Achieves POCMA Certification as First EHR Media Platform Veradigm® (OTCMKTS: MDRX), a leading provider of healthcare data and technology solutions, has made history as the first and only electronic health record (EHR) media provider to receive validation and certification…
